Login to Your Account

Global Concerns

Urgent Need for Antibiotics; Biotechs Carrying the Load

By Peter Winter

Monday, September 16, 2013
Global concern that R&D on new antibiotics has languished in recent years has certainly not escaped the attention of policymakers. The UK, for example, became the latest country to add its voice to the growing crisis about antimicrobial resistance by releasing a five-year strategy last week to address the critically thin pipeline of new antibiotics and the increasing incidence of infections that are becoming more and more difficult to treat.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription